Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era.

To identify and address the challenges associated with the care of ACS patients during the coronavirus 2019 pandemic. The COVID-19 pandemic has had a considerable global impact with over 2.0 million deaths worldwide so far. There has been considerable evidence suggesting that COVID-19 increases the risk of acute coronary syndromes (ACS). We propose characterizing ACS patients into 3 distinct categories to better assist in appropriate triage and management: critically ill patients, non-critically ill ST elevation myocardial infarction (STEMI) patients, and non-critically ill non-ST elevation myocardial infarction (NSTEMI)/unstable angina (UA) patients. We thoroughly review treatments strategies, management considerations, and current consensus statements for the care of COVID-19 patients with ACS. As we continue to gain more experience with management of COVID-19 in ACS patients and as health-care workers and patients continue to get vaccinated, we must continue to adapt our strategies to treat this high-risk group of patients.

Citation

Sanket Borgaonkar, Joshua Hahn, Marilyne Daher, Waleed Kayani, Hani Jneid. Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era. Current cardiology reports. 2021 May 07;23(6):69

Mesh Tags

PMID: 33961122

search → result